Several new markers have been suggested that could, alone or in combination with AFP, improve the accuracy of diagnosing HCC, such as AFP-L3, DCP/PIVKAII, CA242 or AAG [37-40]. The gene discussed is ACE; the disease is hepatocellular carcinoma.